AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Sunlight, Visible Light, and Personalized Photoprotection in Dermatology

Description

The presentation reviews how sunlight affects the skin and how photoprotection should be tailored to individual needs. It explains that UV makes up only a small fraction of sunlight, while visible light and infrared also have biologic effects. Visible light, once thought inert, can cause erythema and, especially in darker skin, strong and persistent pigmentation through blue-light activation of Opsin-3 in melanocytes, leading to calcium influx, increased melanin production, and reduced melanosome degradation. Studies also show synergistic pigmentation when visible light is combined with UVA1, and shorter visible wavelengths such as blue and green light are most responsible. The talk then covers photoaging and photocarcinogenesis, including UV-driven MMP activation and collagen breakdown. For protection, it emphasizes a total package: shade, clothing, hats, sunglasses, sunscreens, and emerging non-topical agents. Tinted sunscreens with iron oxides are highlighted as best for visible light protection in the U.S., while several European filters offer broader UVA/visible-light coverage. The speaker notes the proposed U.S. approval of BEMT/Tinosorb S, a photostable broad-spectrum filter with minimal absorption. A review of non-filtering photoprotective agents found that most evidence is weak, with only a small fraction supported by strong clinical data; top candidates include antioxidants, depigmenting agents, and DNA repair enzymes. Finally, the talk stresses personalized photoprotection based on skin type, genome, microbiome, and exposome, noting that lighter skin needs higher SPF for sunburn and cancer prevention, while darker skin may particularly benefit from better UVA and visible-light protection to prevent pigmentation. The overall message is evidence-based, balanced, individualized photoprotection.

View more

Conclusions

  • Visible light is now recognized as a meaningful biologic trigger in dermatology, especially for pigmentation and tanning in darker skin, rather than being inert.
  • Blue light appears to be the key visible-light wavelength driving pigmentation, largely through Opsin-3 signaling in melanocytes and suppression of autophagy, which helps explain persistent darkening.
  • Visible light can produce more sustained pigmentary changes than UVA1 in darker skin, and combining visible light with UVA1 can have synergistic effects on tanning.
  • Photoaging is primarily driven by UV-induced collagen damage and imperfect repair, while darker skin shows less photoaging and more photoprotection from its higher melanin content.
  • Photocarcinogenesis remains a major established harm of sunlight, but the presentation also emphasizes that sunlight may have some beneficial effects that should be acknowledged.
  • Effective photoprotection should be viewed as a total package that includes shade, clothing, hats, sunglasses, sunscreens, and sometimes non-topical agents.
  • For visible-light protection, tinted sunscreens containing iron oxides are currently the best practical option in the United States.
  • Newer filters and broader-spectrum sunscreen ingredients, such as bemotrizinol, may improve protection against long-wave UVA and visible light and could eventually expand U.S. options.
  • Biological photoprotection with topical non-filtering ingredients is an emerging strategy, but most proposed agents still have weak clinical evidence.
  • Among non-filtering photoprotective ingredients, vitamin C, nicotinamide, green-tea polyphenols, vitamin E, thiamidol, N-acetylcysteine, photolyase, and melasyl appear to be the strongest performers.
  • Photoprotection recommendations should be personalized rather than one-size-fits-all, with sunscreen choice and SPF targets tailored to skin phototype and risk profile.
  • Light-skinned individuals generally need higher SPF and stronger UV protection, while darker-skinned individuals may especially benefit from UVA and visible-light protection to reduce pigmentary changes.
  • Current sunscreen labeling and regulatory standards still do not adequately quantify visible-light protection, making counseling and product selection more challenging.
  • The overall message is that dermatology should promote balanced, evidence-based, individualized sun protection rather than blanket avoidance of sunlight.
  • Mahmoud BH, et al. J Invest Dermatol. 2010;130:2092.
  • Duteil L, et al. (references on VL/blue light and Opsin-3).
  • Passeron et al. (references on VL/blue light and Opsin-3).
  • Reggazetti et al. (references on VL/blue light and Opsin-3).
  • Yu et al. (references on VL/blue light and Opsin-3).
  • Marionnet C, Bernerd F. JEADV. 2023 Apr;37 Suppl 4:3-11.
  • Taylor S, Lim HW. J Am Acad Dermatol. 2021/2022 Mar;86(3S):S9-S17.
  • Fisher GJ, Voorhees JJ. N Engl J Med. 1997;337:1419.
  • Kripke ML. J Natl Cancer Inst. 1974;53:1333.
  • Towes GB. J Immunol. 1980;124:445.
  • Bolognia: Dermatology. 4th ed. 2018.
  • Jansen R, et al. J Am Acad Dermatol. 2013;69:853 & 866.
  • Personalized photoprotection: Commentary on 'Adjusting best practices in the treatment of melasma with a focus on patients with skin of color'. J Am Acad Dermatol. 2023 Sep;89:635.#10.1016/j.jaad.2023.05.038
  • New trends on personalized sunscreens. Photodermatol Photoimmunol Photomed. 2024 Apr;40:e12967.#10.1111/phpp.12967
  • Personalized Photoprotection: Expert Consensus and Recommendations From a Delphi Study Among Dermatologists. PMID/PMCID/DOI listed.#10.1111/phpp.70001
  • Passeron et al. JEADV. 2021.
  • Brown et al. (British Journal of Dermatology reference on PINGs).
  • Krutmann et al. (Photodermatology, Photoimmunology & Photomedicine reference on PINGs).